Literature DB >> 20305089

Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency.

Xiao-Sheng Jiang1, Peter S Backlund, Christopher A Wassif, Alfred L Yergey, Forbes D Porter.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) and lathosterolosis are malformation syndromes with cognitive deficits caused by mutations of 7-dehydrocholesterol reductase (DHCR7) and lathosterol 5-desaturase (SC5D), respectively. DHCR7 encodes the last enzyme in the Kandutsch-Russel cholesterol biosynthetic pathway, and impaired DHCR7 activity leads to a deficiency of cholesterol and an accumulation of 7-dehydrocholesterol. SC5D catalyzes the synthesis of 7-dehydrocholesterol from lathosterol. Impaired SC5D activity leads to a similar deficiency of cholesterol but an accumulation of lathosterol. Although the genetic and biochemical causes underlying both syndromes are known, the pathophysiological processes leading to the developmental defects remain unclear. To study the pathophysiological mechanisms underlying SLOS and lathosterolosis neurological symptoms, we performed quantitative proteomics analysis of SLOS and lathosterolosis mouse brain tissue and identified multiple biological pathways affected in Dhcr7(Delta3-5/Delta3-5) and Sc5d(-/-) E18.5 embryos. These include alterations in mevalonate metabolism, apoptosis, glycolysis, oxidative stress, protein biosynthesis, intracellular trafficking, and cytoskeleton. Comparison of proteome alterations in both Dhcr7(Delta3-5/Delta3-5) and Sc5d(-/-) brain tissues helps elucidate whether perturbed protein expression was due to decreased cholesterol or a toxic effect of sterol precursors. Validation of the proteomics results confirmed increased expression of isoprenoid and cholesterol synthetic enzymes. This alteration of isoprenoid synthesis may underlie the altered posttranslational modification of Rab7, a small GTPase that is functionally dependent on prenylation with geranylgeranyl, that we identified and validated in this study. These data suggested that although cholesterol synthesis is impaired in both Dhcr7(Delta3-5/Delta3-5) and Sc5d(-/-) embryonic brain tissues the synthesis of nonsterol isoprenoids may be increased and thus contribute to SLOS and lathosterolosis pathology. This proteomics study has provided insight into the pathophysiological mechanisms of SLOS and lathosterolosis, and understanding these pathophysiological changes will help guide clinical therapy for SLOS and lathosterolosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305089      PMCID: PMC2938083          DOI: 10.1074/mcp.M900548-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  80 in total

Review 1.  Rab proteins, connecting transport and vesicle fusion.

Authors:  Ingrid Jordens; Marije Marsman; Coen Kuijl; Jacques Neefjes
Journal:  Traffic       Date:  2005-12       Impact factor: 6.215

2.  Two-dimensional gel electrophoresis maps of the proteome and phosphoproteome of primitively cultured rat mesangial cells.

Authors:  Xiao-Sheng Jiang; Liu-Ya Tang; Xing-Jun Cao; Hu Zhou; Qi-Chang Xia; Jia-Rui Wu; Rong Zeng
Journal:  Electrophoresis       Date:  2005-12       Impact factor: 3.535

Review 3.  SREBPs: protein interaction and SREBPs.

Authors:  Ryuichiro Sato
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

4.  Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.

Authors:  H Waage-Baudet; W C Dunty; D B Dehart; S Hiller; K K Sulik
Journal:  Dev Neurosci       Date:  2005       Impact factor: 2.984

5.  A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study.

Authors:  Erin E Berring; Kimberly Borrenpohl; Steven J Fliesler; Alexa Barnoski Serfis
Journal:  Chem Phys Lipids       Date:  2005-07       Impact factor: 3.329

Review 6.  Rho proteins, mental retardation and the neurobiological basis of intelligence.

Authors:  Elly J M van Galen; Ger J A Ramakers
Journal:  Prog Brain Res       Date:  2005       Impact factor: 2.453

7.  Oxidative stress in patients with phenylketonuria.

Authors:  L R Sirtori; C S Dutra-Filho; D Fitarelli; A Sitta; A Haeser; A G Barschak; M Wajner; D M Coelho; S Llesuy; A Belló-Klein; R Giugliani; M Deon; C R Vargas
Journal:  Biochim Biophys Acta       Date:  2005-02-25

8.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.

Authors:  H R Waterham; F A Wijburg; R C Hennekam; P Vreken; B T Poll-The; L Dorland; M Duran; P E Jira; J A Smeitink; R A Wevers; R J Wanders
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

9.  Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications.

Authors:  Xiao-Sheng Jiang; Christopher A Wassif; Peter S Backlund; Li Song; Lynne A Holtzclaw; Zheng Li; Alfred L Yergey; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

10.  Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.

Authors:  B U Fitzky; M Witsch-Baumgartner; M Erdel; J N Lee; Y K Paik; H Glossmann; G Utermann; F F Moebius
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  20 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Desmosterolosis and desmosterol homeostasis in the developing mouse brain.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  J Inherit Metab Dis       Date:  2019-04-08       Impact factor: 4.982

3.  Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley-Bixler syndrome.

Authors:  Rok Keber; Helena Motaln; Kay D Wagner; Nataša Debeljak; Minoo Rassoulzadegan; Jure Ačimovič; Damjana Rozman; Simon Horvat
Journal:  J Biol Chem       Date:  2011-06-25       Impact factor: 5.157

4.  DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.

Authors:  Libin Xu; Karoly Mirnics; Aaron B Bowman; Wei Liu; Jennifer Da; Ned A Porter; Zeljka Korade
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

5.  Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Authors:  Peter M Elias; Mary L Williams; Kenneth R Feingold
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

Review 6.  Smith-Lemli-Opitz syndrome.

Authors:  Andrea E DeBarber; Yasemen Eroglu; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Expert Rev Mol Med       Date:  2011-07-22       Impact factor: 5.600

Review 7.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

Review 8.  The Role of Cholesterol in Cancer.

Authors:  Omer F Kuzu; Mohammad A Noory; Gavin P Robertson
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

9.  ProteinProcessor: A probabilistic analysis using mass accuracy and the MS spectrum.

Authors:  Jonathan A Epstein; Paul S Blank; Brian C Searle; Aaron D Catlin; Stephanie M Cologna; Matthew T Olson; Peter S Backlund; Jens R Coorssen; Alfred L Yergey
Journal:  Proteomics       Date:  2016-09       Impact factor: 3.984

10.  Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia.

Authors:  Wayne A Cabral; Nadja Fratzl-Zelman; MaryAnn Weis; Joseph E Perosky; Adrienne Alimasa; Rachel Harris; Heeseog Kang; Elena Makareeva; Aileen M Barnes; Paul Roschger; Sergey Leikin; Klaus Klaushofer; Antonella Forlino; Peter S Backlund; David R Eyre; Kenneth M Kozloff; Joan C Marini
Journal:  Matrix Biol       Date:  2020-02-26       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.